Yael Capital Management Limited
VC Fund
Yael Capital Management Limited is a VC fund focused on Biotechnology and Pharmaceutical. Yael Capital is an investment management company that focuses on private equity investment and fund management. The company is mainly focused in early investments in biotechnology companies and other fields. Yael Capital was founded in 2018 and is based in Shenzhen, China.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Yael Capital Management Limited invests in
Stages Yael Capital Management Limited invests in
Countries Yael Capital Management Limited invests in
Investment Focus
Industry
- Biotechnology 13 (65%)
- Pharmaceutical 7 (35%)
- Medical 5 (25%)
- Health Care 4 (20%)
- Artificial Intelligence 4 (20%)
Stage
- Seed 6 (30%)
- Series A 4 (20%)
- Angel 2 (10%)
- Series B 2 (10%)
- Pre-Seed 1 (5%)
Country
- China 9 (45%)
- United States 6 (30%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xellar Biosystems
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $29.5M / Series A / Jun 30, 2026 | |
|
Xellar Biosystems
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $29M / Series A / Apr 02, 2026 | |
Insight Technology
|
Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more. | Seed / Mar 23, 2026 | |
Foundry BioSciences
|
Foundry BioSciences is a biotechnology company at the forefront of integrating artificial intelligence (AI) with protein engineering to address challenges in longevity science and extend human healthspan. The company is dedicated to developing advanced protein language models using deep learning, | Pre-Seed / Jul 02, 2025 | |
|
Xellar Biosystems
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | Seed / Apr 28, 2025 | |
META Pharmaceuticals
|
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases. | Venture - Series Unknown / Feb 17, 2025 | |
Merda Biopharma
|
Merda Biopharma is a AI-enabled drug discovery technology platform that produces small molecule drugs that helps immune metabolism. | Series A / Feb 14, 2025 | |
ReviR Therapeutics
|
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. | $30M / Series A / Jul 26, 2024 | |
|
Xellar Biosystems
|
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | $13.8M / Seed / Jul 17, 2024 | |
Recorna Bio
|
Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise. | Seed / Jun 28, 2024 | |
| See all 20 investments → | |||
Co-Investors
Tiantu Capital
7 deals together
XtalPi
7 deals together
5Y Capital
6 deals together
IMO Ventures
4 deals together
Legend Capital
4 deals together
Taihill Venture
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Yael Capital Management Limited invest in?
Yael Capital Management Limited invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Seed and Series A stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yael Capital Management Limited last invest?
The most recent investment recorded for Yael Capital Management Limited closed in Jun 2026. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
